Ocular Therapeutix stockOCUL
Ocular Therapeutix trades at $6.43, 60.9% below its 52-week high (Dec 8, 2025). The price is below its 50- and 200-day averages, a downtrend. −47.0% year to date, −40.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for OCUL — after you log in
Open the terminalFrequently asked questions about Ocular Therapeutix
What is the Ocular Therapeutix stock price?
At the close on Nov 5, 2026: $6.43 (−9.94% on the day). 52-week high: $16.44 on Dec 8, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ocular Therapeutix report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed +10% year over year, revenue 0%.
Does Ocular Therapeutix pay dividends?
No, Ocular Therapeutix does not pay dividends.
Where does Ocular Therapeutix trade and how to buy it?
Ticker OCUL, exchange Nasdaq, listed since 2014. You can buy it through a broker with access to US exchanges.
Should I buy Ocular Therapeutix now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for OCUL are in the terminal after you log in.